BROVARABIES V-RG
BROVARABIES V-RG
Authorised
- Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Product identification
Medicine name:
BROVARABIES V-RG
Active substance:
- Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Target species:
-
Wild animals
-
Fox
-
Wolf
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Vaccinia virus, expressing glycoprotein gene of rabies virus, Live8.00/log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Block
Withdrawal period by route of administration:
-
Oral use
- Wild animals
- Fox
- Wolf
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Sam Bs EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
- Sam Bs EOOD
Responsible authority:
- BFSA
Authorisation number:
- 0022-2762
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/02/2023
How useful was this page?:
